Leukemia Research
Volume 24, Issue 7 , Pages 583-587, July 2000

Treatment of patients with advanced chronic myelogenous leukemia with interferon-alpha-2b and continuous oral cytarabine ocfosfate (YNK01):

a pilot study

  • T Kühr

      Affiliations

    • Department of Internal Medicine, University Hospital, Anichstrasse 35, 6020 Innsbruck, Austria
    • Corresponding Author InformationCorresponding author. Tel./fax: +43-512-5043333
  • ,
  • W Eisterer

      Affiliations

    • Department of Internal Medicine, University Hospital, Anichstrasse 35, 6020 Innsbruck, Austria
  • ,
  • U Apfelbeck

      Affiliations

    • Department of Internal Medicine, University Hospital, Graz, Austria
  • ,
  • W Linkesch

      Affiliations

    • Department of Internal Medicine, University Hospital, Graz, Austria
  • ,
  • O Bechter

      Affiliations

    • Department of Internal Medicine, University Hospital, Anichstrasse 35, 6020 Innsbruck, Austria
  • ,
  • A Zabernigg

      Affiliations

    • Department of Internal Medicine, General Hospital, Kufstein, Austria
  • ,
  • K Geissler

      Affiliations

    • Department of Internal Medicine, University Hospital, Vienna, Austria
  • ,
  • G Barbieri

      Affiliations

    • Department of Internal Medicine, General Hospital, St. Pölten, Austria
  • ,
  • C Duba

      Affiliations

    • Department of Medical Biology and Human Genetics, University of Innsbruck, Innsbruck, Austria
  • ,
  • G Gastl

      Affiliations

    • Department of Internal Medicine, University Hospital, Anichstrasse 35, 6020 Innsbruck, Austria
  • ,
  • J Thaler

      Affiliations

    • Department of Internal Medicine, University Hospital, Anichstrasse 35, 6020 Innsbruck, Austria

Received 11 February 2000; accepted 3 March 2000.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0145-2126(00)00036-9

Leukemia Research
Volume 24, Issue 7 , Pages 583-587, July 2000